Skip to main content
Displaying 13 - 24 of 31
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Linking the pathophysiology of MASH to its metabolic comorbidities
Webcasts
View
Metabolism, Alcohol & Toxicity
Approaching MASH as a metabolic disease to reduce outcomes
Webcasts
View
Metabolism, Alcohol & Toxicity
Panel Discussion (Q & A)
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Addressing NASH as a chronic metabolic disease: the need for a simplified patient referral pathway
Webcasts
View
Metabolism, Alcohol & Toxicity
Simplifying the patient referral pathway in NASH: expert opinion
Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion and Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Summary and conclusion
Webcasts
View
Metabolism, Alcohol & Toxicity
Why we need to talk about NASH
Webcasts
View
Metabolism, Alcohol & Toxicity
Hepatic consequences of metabolic dysregulation: NAFLD and NASH
Webcasts
View
Metabolism, Alcohol & Toxicity
Looking ahead: how to identify high-risk patients
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy